Inferring chromosomal instability from copy number aberrations as a measure of chromosomal instability across human cancers

Background Cancer is a complex disease that is the second leading cause of death in the United States. Despite research efforts, the ability to manage cancer and select optimal therapeutic responses for each patient remains elusive. Chromosomal instability (CIN) is primarily a product of segregation errors wherein one or many chromosomes, in part or whole, vary in number. CIN is an enabling characteristic of cancer, contributes to tumor-cell heterogeneity, and plays a crucial role in the multistep tumorigenesis process, especially in tumor growth and initiation and in response to treatment. Aims Multiple studies have reported different metrics for analyzing copy number aberrations as surrogates of CIN from DNA copy number variation data. However, these metrics differ in how they are calculated with respect to the type of variation, the magnitude of change, and the inclusion of breakpoints. Here we compared metrics capturing CIN as either numerical aberrations, structural aberrations, or a combination of the two across 33 cancer data sets from The Cancer Genome Atlas (TCGA). Methods and results Using CIN inferred by methods in the CINmetrics R package, we evaluated how six copy number CIN surrogates compared across TCGA cohorts by assessing each across tumor types, as well as how they associate with tumor stage, metastasis, and nodal involvement, and with respect to patient sex. Conclusions We found that the tumor type impacts how well any two given CIN metrics correlate. While we also identified overlap between metrics regarding their association with clinical characteristics and patient sex, there was not complete agreement between metrics. We identified several cases where only one CIN metric was significantly associated with a clinical characteristic or patient sex for a given tumor type. Therefore, caution should be used when describing CIN based on a given metric or comparing it to other studies.

[1]  J. Ragoussis,et al.  Evolution of chromosome arm aberrations in breast cancer through genetic network rewiring , 2023, bioRxiv.

[2]  Allen W. Zhang,et al.  Single-cell genomic variation induced by mutational processes in cancer , 2022, Nature.

[3]  Choung-Soo Kim,et al.  Sex Differences in the Prevalence of Head and Neck Cancers: A 10-Year Follow-Up Study of 10 Million Healthy People , 2022, Cancers.

[4]  E. Obersztyn,et al.  Comparative Genomic Hybridization to Microarrays in Fetuses with High-Risk Prenatal Indications: Polish Experience with 7400 Pregnancies , 2022, Genes.

[5]  D. Hanahan Hallmarks of Cancer: New Dimensions. , 2022, Cancer discovery.

[6]  B. Mazur,et al.  Genetic and immunophenotypic diversity of acute leukemias in children , 2022, Postępy Higieny i Medycyny Doświadczalnej.

[7]  Brittany N. Lasseigne,et al.  CINmetrics: an R package for analyzing copy number aberrations as a measure of chromosomal instability , 2021, bioRxiv.

[8]  Jason M. Sheltzer,et al.  Chromosomal instability and aneuploidy as causes of cancer drug resistance. , 2021, Trends in cancer.

[9]  David R. Jones,et al.  Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients , 2021, Cell.

[10]  D. M. Miedema,et al.  Chromosomal copy number heterogeneity predicts survival rates across cancers , 2021, Nature Communications.

[11]  M. Bloomfield,et al.  Karyotype Aberrations in Action: The Evolution of Cancer Genomes and the Tumor Microenvironment , 2021, Genes.

[12]  J. Kendall,et al.  Chromosomal instability accelerates the evolution of resistance to anti-cancer therapies , 2020, bioRxiv.

[13]  Nicolai J. Birkbak,et al.  Pervasive chromosomal instability and karyotype order in tumour evolution , 2020, Nature.

[14]  Alboukadel Kassambara,et al.  Pipe-Friendly Framework for Basic Statistical Tests [R package rstatix version 0.6.0] , 2020 .

[15]  Haoyang Cai,et al.  The Landscape of Somatic Copy Number Alterations in Head and Neck Squamous Cell Carcinoma , 2020, Frontiers in Oncology.

[16]  S. McClelland,et al.  The emerging links between chromosomal instability (CIN), metastasis, inflammation and tumour immunity , 2019, Molecular Cytogenetics.

[17]  K. McManus,et al.  Detecting Chromosome Instability in Cancer: Approaches to Resolve Cell-to-Cell Heterogeneity , 2019, Cancers.

[18]  Martin F Krapcho,et al.  Head and neck squamous cell cancers in the United States are rare and the risk now is higher among white individuals compared with black individuals , 2018, Cancer.

[19]  G. Kops,et al.  Difference Makers: Chromosomal Instability versus Aneuploidy in Cancer. , 2016, Trends in cancer.

[20]  Roland Eils,et al.  Complex heatmaps reveal patterns and correlations in multidimensional genomic data , 2016, Bioinform..

[21]  Gianluca Bontempi,et al.  TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data , 2015, Nucleic acids research.

[22]  A. Azmi,et al.  Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition , 2015, Seminars in cancer biology.

[23]  J. Davison,et al.  The Degree of Segmental Aneuploidy Measured by Total Copy Number Abnormalities Predicts Survival and Recurrence in Superficial Gastroesophageal Adenocarcinoma , 2014, PloS one.

[24]  A. Børresen-Dale,et al.  High Levels of Genomic Aberrations in Serous Ovarian Cancers Are Associated with Better Survival , 2013, PloS one.

[25]  P. Kuo,et al.  The tumor microenvironment. , 2012, Surgical oncology.

[26]  C. Swanton,et al.  Cancer chromosomal instability: therapeutic and diagnostic challenges , 2012, EMBO reports.

[27]  D. Compton,et al.  Chromosomal instability and cancer: a complex relationship with therapeutic potential. , 2012, The Journal of clinical investigation.

[28]  Prabhjot Kaur,et al.  Chromosomal Instability Substantiates Poor Prognosis in Patients with Diffuse Large B-cell Lymphoma , 2011, Clinical Cancer Research.

[29]  Zoltan Szallasi,et al.  Paradoxical relationship between chromosomal instability and survival outcome in cancer. , 2011, Cancer research.

[30]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[31]  Nicolai J. Birkbak,et al.  Chromosomal instability confers intrinsic multidrug resistance. , 2011, Cancer research.

[32]  D. Compton,et al.  Mechanisms of Chromosomal Instability , 2010, Current Biology.

[33]  Hui-Ping Zhao,et al.  Chromosome instability and risk of squamous cell carcinomas of head and neck. , 2008, Cancer research.

[34]  S. Tavaré,et al.  High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer , 2007, Genome Biology.

[35]  H. B. Mann,et al.  On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other , 1947 .

[36]  Frank Wilcoxon,et al.  Some uses of statistics in plant pathology , 1945 .

[37]  A. Amon,et al.  Context is everything: aneuploidy in cancer , 2019, Nature Reviews Genetics.

[38]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[39]  Cristina Montagna,et al.  Aneuploidy acts both oncogenically and as a tumor suppressor. , 2007, Cancer cell.

[40]  Max F. Meyer,et al.  The Proof and Measurement of Association between Two Things. , 1904 .